2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$48.35+$0.11 (+0.23%)
Price as of Aug 21, 2026 7:30 PM EDT- $2.3BMarket Cap
- 226.61%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$48.35+$0.11 (+0.23%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $48.24 | ||
Change | +$0.39 (+0.82%) | ||
Open | $48.36 | ||
High | $48.50 | ||
Low | $47.48 | ||
Previous Close | $47.85 | ||
Volume | 140,870 | ||
30-Day Average Volume | 273,580 | ||
1-Week Change | 1.73% | ||
1-Month Change | 13.35% | ||
1-Year Change | 226.61% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 48.0M | ||
Total Assets | $459.0M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$56.6M | ||
Free Cash Flow | -$41.5M | ||
EBIT | -$56.6M | ||
EBITDA | -$56.4M | ||
Net Working Capital | $418.4M | ||
EPS | -$1.19 | ||
Enterprise Value/EBITDA | -40 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -41 | ||
PEG | 0 | ||
Price/Free Cash Flow | -56 | ||
Price/Operating Cash Flow | -56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue